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 Obstructive sleep apnea (OSA) and narcolepsy cause excessive daytime sleepiness 
(EDS) and hypersomnia. Daytime sleepiness can be measured by the maintenance of 
wakefulness test (MWT). OSA and upper airway resistence syndrome (UARS) patients 
frequently have abnormal MWTs. Co-morbidities and medication of patients are likely 
to influence the results of MWT. We set out to study the association between MWT 
sleep latencies and patients’ background characteristics and co-morbidity.  
 
We studied retrospectively 506 MWTs in 361 patients. MWT testing was performed 
between January 2006 and November 2014. We gathered also information about age, 
gender, BMI, smoking, snoring, waist circumference, disease burden, diagnostic 
cardiovascular polygraphy, medication, CPAP-treatment, ESS, GHQ-12 and DEPS 
scores and subjective sleep quality. Then we examined how sleep latiencies in the 
MWT were influenced by these factors. 
 
We found that professional drivers, sleep apnea patients and men were more alert than 
non-professional drivers, patients without sleep apnea or women, respectively. Patients 
suffering from long-term snoring and using almost all types of medication had worse 
results in MWT compared to others. Higher scores in ESS, GHQ-12 and DEPS 
questionnaires associated with shorter sleep latencies. We conclude that gender, sleep 
disorder type, co-morbidity and medication influence the results of MWT. 
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Abstract 
Objectives: Obstructive sleep apnea (OSA) and narcolepsy cause excessive daytime 
sleepiness (EDS) and hypersomnia. Daytime sleepiness can be measured by the 
maintenance of wakefulness test (MWT). OSA and upper airway resistence syndrome 
(UARS) patients frequently have abnormal MWTs. Co-morbidities and medication of 
patients are likely to influence the results of MWT. We set out to study the association 
between MWT sleep latencies and patients background characteristics and co-
morbidity. 
Methods: We studied retrospectively 506 MWTs in 361 patients. MWT testing was 
performed between January 2006 and November 2014. We gathered also information 
about age, gender, BMI, smoking, snoring, waist circumference, disease burden, apnea-
hypopnea index (AHI), oxygen desaturation index of 4 percentage points (ODI4) and 
mean oxygen saturation during a diagnostic cardiovascular polygraphy, medication, 
CPAP-treatment, ESS, GHQ-12 and DEPS scores and subjective sleep quality. Then we 
examined how sleep latiencies in the MWT were influenced by these factors. 
Results: We found that professional drivers, sleep apnea patients and men were more 
alert than non-professional drivers,  patients without sleep apnea or women, 
respectively. Patients suffering from long-term snoring and using almost all types of 
medication had worse results in MWT compared to others. Higher scores in ESS, GHQ-
12 and DEPS questionnaires associated with shorter sleep latencies. 
Conclusions: Gender, sleep disorder type, co-morbidity and medication influence the 
results of MWT. 
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Introduction 
Obstructive sleep apnea (OSA) and narcolepsy are two main sleep disorders to cause 
excessive daytime sleepiness (EDS) and hypersomnia (1). OSA increases the risk of 
cardiovascular diseases, such as hypertension and coronary artery disease (2) and it is 
also associated with diabetes (3, 4, 5), asthma (6,7) and psychiatric diseases such as 
depression (8). It also increases accident likelihood (9).  
 
Daytime sleepiness can be measured in several ways. The Epworth Sleepiness Scale 
(ESS) is a brief and simple questionnaire-based scale which measures the propensity to 
fall asleep at daytime (10). ESS, however, is a subjective test and good objective 
measures of vigilance are needed.  
 
Impaired daytime alertness can be identified with the maintenance of wakefulness test 
(MWT) in a sleep laboratory. The response to treatment of excessive sleepiness can also 
be assessed with MWT. (11) MWT is a costly in-laboratory test where the patient is 
requested to stay awake for 40 minutes while sitting comfortably in a non-stimulating 
room with dim light and electroencephalography (EEG) is recorded to observe sleep 
onset. There are four MWT trials with two hours in between. (12)  
 
Obstructive sleep apnea (OSA) and upper airway resistance syndrome (UARS) patients 
frequently have abnormal MWTs (13), but it has been shown that patients treated with 
continuous positive airway pressure (CPAP) have better MWT results as compared to 
patients without treatment (14). Narcolepsy patients also seem to fall asleep faster in 
MWT compared to those without narcolepsy (15). 
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Co-morbidities and medication of patients are likely to influence the results of the 
MWT. Therefore, we set out to study the association between MWT sleep latencies and 
patients’ background characteristics and co-morbidity. We wanted to know if higher co-
morbidity of patients with EDS associates with worse results in the MWT. 
 
Methods 
We made a retrospective patient chart review of all patients who had undergone MWT 
testing in the Department of clinical neurophysiology at Turku university hospital, 
Turku, Finland, between January 2006 and November 2014. Clinical and diagnostic 
data was assessed and MWT data re-evaluated for the study. 
 
For the MWT, a MWT40 protocol with four 40-minute recordings at 8 am, 10 am, 12 
noon and 2 pm was used with the international 10-20-system EEG electrodes F3, F4, 
C3, C4, O1 and O2 in combination with left and right electro-oculogram and submental 
electromyogram, according to the AASM recommendations (11). 
 
 The patient was observed via digital video and a technician marked eye opening and 
closing on the recording online. The patients reported subjective total sleep time from 
the previous night before the MWT. For the evaluation of daytime somnolence, ESS, 
with scores over ten points out of a maximum of 24 considered abnormal, was used. 
The patients also filled in the General Health Questionnaire-12 (GHQ-12) (in which at 
least three points out of a maximum score of 12 was considered abnormal) for the 
evaluation of possible psychiatric disorders. Further, the patients filled in the depression 
questionnaire (DEPS) in which at least nine points out of the maximum score of 30 
points was considered as suggestive of depression. (16) 
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Original MWT data were reanalyzed by an experienced clinical neurophysiologist (I.V.) 
defining N1 sleep latency from lights off to the appearance of theta of drowsiness of at 
least ten consecutive seconds’ duration OR at least fifteen seconds’ duration during a 
thirty second epoch for each recording as originally defined by Doghramji et al (12). 
 
All in all 518 MWTs in 370 patients were found but after all 506 MWTs in 361 patients 
were included in the fina data set. Nine MWTs and one recording session from 3 MWTs 
was missing and these were rejected from the final analyses. (16) From the patient 
charts, we gathered all available information about age, gender, BMI, smoking, snoring, 
waist circumference, disease burden such as sleep apnea, hypertension, hypothyroidism, 
and mood disorders, apnea-hypopnea index (AHI), oxygen desaturation index of 4 
percentage points (ODI4) and mean oxygen saturation during a diagnostic 
cardiovascular polygraphy, medication defined by ATC codes, CPAP-treatment 
compliance in actual hours used, ESS, GHQ-12 and DEPS scores and the best and worst 
subjective sleep quality in a previous sleep diary on a scale of 0-10 where 10 marks best 
possible quality. We then examined how the mean and minimum sleep latencies in the 
MWT were influenced by these factors.   
 
Statistics 
Statistical analyses were made using SPSS ver. 22 software. We used the Mann-
Whitney U test to evaluate group differences in dichotomous variables such as gender, 
sleep apnea, basic diseases, CPAP treatment use and the use of different types of 
medications. We also used Spearman correlation coefficients to evaluate correlation 
between MWT results and the continuous variables such as age, BMI, waist 
circumference, snoring, cardiovascular polygraphy results, ESS, GHQ-12, and DEPS 
scores, and sleep quality. A p-value of <0.05 was considered statistically significant. 
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Ethics 
The Advisory board of the Hospital District of Southwest Finland accepted this study. 
Database sample size was large so informed consent from the patients was not required.   
 
Results 
Most of the 361 patients were men (91,4%), professional drivers (85,3%) and sleep 
apnea patients (91,7%). Many of the patients had other diseases (hypertension, 
hypothyroidism and mood disorders) and the medication load was heavy.  (Table 1) 
 
Professional drivers had longer mean and minimum sleep latencies compared to other 
drivers, and men had longer mean and minimum sleep latencies compared to women. 
Patients who suffered from sleep apnea had longer mean and minimum sleep latencies 
than those suffering from other types of hypersomnia, while patients on narcolepsy 
medication had shorter mean and minimum sleep latencies compared to other patients. 
Consequently, this indicates that professional drivers, men and sleep apnea patients 
stayed awake better than non-professional drivers, women or other hypersomnia 
patients, respectively. (Table 2) 
 
Patients with hypertension had longer mean and minimum sleep latencies as compared 
to patients without hypertension. The use of cardiovascular medication was also 
associated with longer mean sleep latencies and the use of statins was associated with 
longer mean and minimum sleep latencies. Patients with hypothyroidism had shorter 
mean and minimum sleep latencies as compared to others. Shorter mean sleep latencies 
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were also associated with mood disorders and the use of antidepressants.  Patients who 
used neuropsychiatric medication had shorter minimum sleep latencies as compared to 
the others. This indicates that patients having cardiovascular diseases seem to be more 
alert compared to others. Instead other co-morbidities and almost all other medication 
use seem to cause increased tiredness.  (Table 2) 
 
No correlation was found between MWT results and age, BMI or waist circumference. 
Nor were any correlations observed between MWT results and AHI, AHI in supine 
position, ODI4, mean or minimum oxygen saturation during a diagnostic cardiovascular 
polygraphy, smoking load in packet years, CPAP pressure, maximum or minimum 
duration of sleep or best sleep quality in the preceding sleep diary and the duration of 
sleep during the preceding night. (Table 3) 
 
There was a significant correlation between shorter minimum and mean sleep latencies 
and duration of snoring, indicating that long term snorers are less alert. Logically longer 
CPAP using hours, as well as lower ESS, GHQ-12, and DEPS scores correlated with 
longer minimum and mean sleep latencies. In addition, there was a correlation between 
a better score of worst sleep quality in the sleep diary and longer minimum and mean 
sleep latencies. This indicates patients who slept worse before testing performed also 
worse in the MWT. (Table 3) 
 
Discussion 
In this large retrospective study of patients suffering from excessive daytime sleepiness 
undergoing MWT vigilance test, we found that professional drivers, sleep apnea 
patients and men were more alert than non-professional drivers, patients without sleep 
apnea or women, respectively. Long-term snoring and almost all types of medication for 
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comorbidities worsened the MWT results. Also, higher scores in ESS, GHQ-12 and 
DEPS questionnaires were associated with shorter sleep latencies.       
 
We found that non-professional drivers fell asleep faster in MWT compared to 
professional drivers, when patients had EDS. Previously Anund et al. found that 
professional drivers had longer blink durations and more line crossings while driving in 
a simulator compared to non-professional drivers, indicating that professional drivers 
were sleepier than others in the driving simulator test (17). MWT and driving simulator  
are two completely different tests which probably explain the difference.   
 
In our study sleep apnea patients had longer sleep latencies than other hypersomnia 
patients. We also found that patients using narcolepsy medication had shorter sleep 
latencies compared to those who did not. Previous research has also found that 
untreated narcolepsy patients performed significantly worse in a driving simulator test 
than untreated sleep apnea patients (18). Our data included 331 sleep apnea patients and 
29 patients had some other form of hypersomnia (including narcolepsy). In the sleep 
apnea patient group, we found a significant correlation between CPAP using hours and 
longer sleep latencies indicating a good treatment effect. Indeed, previous data shows 
that CPAP treatment lengthens MWT sleep latencies by 2.1 minutes. (19)  
 
Women had shorter sleep latencies than men according to our results. Mitler et al 
studied 530 narcolepsy patients (239 men and 291 women) and found no difference in 
MWT sleep latencies between men and women (15). Our gender distribution, however, 
was not equal, which could have resulted in a sample bias.  
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Self-reported snoring has been shown to be a symptom of sleep apnea (20). In our data 
the longer snoring time in years correlates with shorter sleep latencies. So it seems that 
patients who have suffered from snoring, with or without sleep apnea, for a longer time 
also have a more severe sleep apnea syndrome as measured with daytime sleepiness. 
We also found that if a patient reported better “worst sleep quality” in sleep diary it 
correlated with longer sleep latencies. It indicates that patients who had slept better 
before testing could stay awake significantly better in MWT than those who had slept 
worse.  
 
OSA increases the risk of having cardiovascular diseases (21). Previous research has 
found an association between hypertension and objective daytime sleepiness in patients 
with OSA (22).  Ren et al. also concluded that OSA patients who reported shorter sleep 
duration were more likely to have hypertension that others (23). In addition, previous 
research has found some synergistic adverse effects on the cardiovascular system if a 
patient suffers from both hypertension and OSA (24). Surprisingly, we found that 
cardiovascular medication, statins and hypertension were associated with longer sleep 
latencies. This could be explained by the previous finding that OSA patients having 
insomnia-like symptoms and suffering from nocturnal hypoxemia also seem to have 
more cardiovascular comorbidity (25). One could hypothesize that OSA patients with 
cardiovascular diseases have insomnia-like symptoms more often than expected.  
 
In our data, 57 patients reported using antidepressants but only 48 patients had mood 
disorders. This could be explained by the various indications of antidepressants (for 
example patients using antidepressant as a hypnotic.) We found that patients using 
antidepressants and neuropsychiatric medication had shorter sleep latencies. A study 
performed in the United States compared MWT results between patients with 
  
8 
depression and patients with sleep apnea. They found that if depressed patients slept 
more poorly their level of alertness rose during daytime. On the other hand, the more 
the sleep of sleep apnea patients was disturbed the more they had difficulties in 
maintaining daytime alertness. (26) Many of our patients had both sleep apnea and 
depression and it seems that combination of these two diseases impairs their daytime 
alertness.  
 
Hypothyroidism is very uncommon in OSA patients (27) but hypothyroid patients often 
seem to have disordered breathing (28). Our results showed that hypothyroidism and the 
use of thyroxin are associated with shorter sleep latencies.  
 
Previous studies have found no high correlation between ESS and MWT (29, 30, 31). 
Sforza et al tested sixty patients who suffered from snoring or OSA with HAD (the 
Hospital Anxiety and Depression Scale), TCI (the Temperament and Character 
Inventory), MWT and ESS. They found that higher depression scores were associated 
with impaired daytime alertness as measured with MWT. (32)  Our results indicate a 
statistically significant correlation coefficient between lower ESS, GHQ-12, and DEPS 
scores and longer sleep latencies. However, scatterplots (appendix) show that ESS, 
GHQ-12, and DEPS scores are widely scattered around the fitted linear regression line, 
giving no constant correlation.  
 
The main advantage in our study is the large sample size. Our patients were aged 
between 18-81 years, so the age range was wide, increasing the generalizability of our 
results, especially in sleep apnea patients. Comorbidity was high and medication load as 
well in our group, which indicates that patients needing an MWT represent a group of 
patients who are heavy users of the health care system.  
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There are also some limitations in our study. Because of our retrospective study design, 
patient information was not evenly or consistently recorded in the patient information. 
Our study group included 330 men and 31 women, so the gender differences in our 
results should be estimated with caution.  
 
 
 
Conclusions 
We conclude that professional drivers seem to be more alert in the daytime as compared 
to other patients. Women performed worse in MWT compared to men. Sleep apnea 
patients were more alert than other hypersomnia patients and especially CPAP treatment 
seemed to improve their alertness. Patients who had snored longer were sleepier than 
others. Almost all medication, except for cardiovascular medication, statins and 
euphorizing analgesics, seemed to reduce daytime alertness. Statistically significant 
correlation was found between higher ESS, GHQ and DEPS scores and shorter MWT 
sleep latencies but the figures showed that relationship between these variables is not 
straightforward. 
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Table 1. Descriptive statistics. 
 
  N (%) /mean (SEM) 
Demographics 
 Gender: male 330 (91,4 %) 
 Age (yrs) (N=361) 49,4 (0,5) 
 BMI (kg/m2) (N=353) 33,4 (0,4) 
 Smokers 164 (45,4%) 
 Waist circumference (cm) (N=203) 116,9 (1,2) 
 Professional drivers 308 (85,3 %) 
   
Comorbidity and medication 
 Snorers  44 (12,2%) 
 Snored (yrs) (N=145) 14,5 (0,8) 
 OSAS 331 (91,7%) 
 Hypertension 138 (38,2%) 
 Hypothyroidism  19 (5,3%) 
 Mood disorder 48 (13,3%) 
 Cardiovascular medication 158 (43,8%) 
 Statins 82 (22,7%) 
 Thyroxin 19 (5,3%) 
 Stimulants / narcolepsy medication 12 (3,3%) 
 Antidepressants 57 (15,8%) 
 Euphorizing analgetics 11 (3,0%) 
 Other neuropsychiatric medication 25 (6,9%) 
   
OSA patient characteristics 
 AHI (events/h) (N=326) 28,4 (1,4) 
 ODI4 (events/h) (N=295) 23,9 (1,5) 
 CPAP use  261 (72,3% of all patients) 
 CPAP use time (hh:mm) (N=240) 4:53 (0:09) 
 CPAP pressure (cmH2O) (N=256) 10,8 (0,2) 
   
Pre-MWT evaluation of sleepiness 
 ESS (pts) (N=352) 6,5 (0,2) 
 GHQ (pts) (N=343) 1,9 (0,2) 
 DEPS (pts) (N=236) 5,2 (0,4) 
 Sleep quality (min) (N=258) 5,7 (0,1) 
 Sleep quality (max) (N=258) 8,2 (0,1) 
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Table 2 Effects of demographics, comorbidity and medication on sleep latencies. (Mean 
(SEM)) 
 
  
  Mean sleep latency (mm:ss) Minimum sleep  latency (mm:ss) 
  Yes No P Yes No P 
Gender /male 27:43  0:40 20:44  0:51 0.000 20:44  0:51 11:23  2:14 0.001 
       
Professional driver 28:26  0:40 18:09  1:44 0.000 21:16  0:52 12:13  1:57 0.000 
       
Sleep apnea as cause of 
hypersomnia 
27:37  0:40 19:07  2:17 0.001 20:34  0:50 12:50  2:35 0.004 
       
Comorbidity       
Hypertension 29:11  0:58 25:32  0:51 0.006 22:11 1:19 18:33  1:01 0.014 
Coronary artery disease 27:20   26:55   0.948 20:26   19:55   0.007 
Hypothyroidism 20:04  2:42 27:19  0:40 0.014 10:47  2:43 20:27  0:50 0.007 
Mood disorder 23:29  1:45 27:28  0:41 0.034 16:26  1:58 20:28  0:53 0.189 
Medications       
Thyroxin 21:45  2:43 27:13  0:40 0.053 12:05 2:49 20:22  0:50 0.020 
Statins 29:19  1:16 26:14  0:44 0.038 22:31 1:41 19:11 0:55 0.042 
Antidepressants 23:46  1:38 27:31  0:42 0.021 16:09  1:48 20:39  0:54 0.068 
Stimulants /narcolepsy 
medication 
17:47  3:40 27:14  0:39 0.015 10:48  4:02 20:15 0:49 0.018 
Euphorizing analgesics 22:54  3:42 27:04  0:39 0.207 13:29  3:17 20:08  0:50 0.293 
Other neuropsychiatric 
medication  
22:05  2:43 27:17  1:16 0.059 14:50  3:11 20:19  1:36 0.027 
Cardiovascular  
medication 
28:34  0:55 25:40  0:53 0.033 21:13  1:14 18:56  1:04 0.137 
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Table 3. Correlations between continuous variables and sleep latencies. 
 N 
 
Mean sleep 
latency 
Minimum sleep 
latency 
 r  P r P 
Age (years) 361 0.059 0.267 0.022 0.677 
BMI (kg/m2) 353 0.010 0.852 -0.006 0.910 
Waist circumference (cm) 203 -0.087 0.219 -0.110 0.119 
Smoking (packet years) 164 -0.002 0.976 -0.038 0.630 
Snoring (years) 145 -0.215 0.009 -0.220 0.008 
      
AHI (events / h) 326 0.059 0.286 0.061 0.274 
AHI supine (events / h) 260 0.036 0.563 0.026 0.681 
ODI4 (events / h)  295 0.041 0.485 0.036 0.538 
Mean SpO2 332 -0.082 0.132 -0.066 0.228 
Minimum SpO2 309 0.006 0.922 0.017 0.763 
      
CPAP daily time of use (h) 240 0.152 0.019 0.159 0.014 
CPAP pressure (cmH2O) 262 0.014 0.824 0.032 0.601 
      
Sleep diary      
Best sleep quality (pts, 0-10) 258 0.072 0.248 0.081 0.197 
Worst sleep quality (pts, 0-10) 258 0.157 0.012 0.159 0.010 
Maximum sleep duration (h) 139 -0.020 0.815 -0.002 0.985 
Minimum sleep duration (h) 138 -0.054 0.527 -0.034 0.693 
Sleep time during preceding night (h) 302 0.016 0.781 -0.018 0.760 
      
ESS 352 -0.453 0.000 -0.432 0.000 
GHQ-12 343 -0.276 0.000 -0.274 0.000 
DEPS 236 -0.215 0.001 -0.195 0.003 
 
BMI = Body mass index, AHI = Apnea-hypopnea index, ODI4 = Oxygen desaturation 
index of > 4 percentage points, ESS = Epworth sleepiness scale, GHQ-12 = General 
Health Questioinnaire-12, DEPS = Depression Scale  
Sleep quality assessed as 0 = worst possible sleep quality, 10 = best possible sleep 
quality 
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Figure. MWT sleep latencies vs. ESS, GHQ-12, and DEPS scores, scatterplots and correlation graphs. 
